全文获取类型
收费全文 | 9132篇 |
免费 | 559篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 212篇 |
妇产科学 | 114篇 |
基础医学 | 1288篇 |
口腔科学 | 31篇 |
临床医学 | 862篇 |
内科学 | 2349篇 |
皮肤病学 | 119篇 |
神经病学 | 759篇 |
特种医学 | 352篇 |
外科学 | 1656篇 |
综合类 | 24篇 |
一般理论 | 2篇 |
预防医学 | 375篇 |
眼科学 | 76篇 |
药学 | 592篇 |
中国医学 | 22篇 |
肿瘤学 | 845篇 |
出版年
2023年 | 52篇 |
2022年 | 93篇 |
2021年 | 232篇 |
2020年 | 123篇 |
2019年 | 243篇 |
2018年 | 246篇 |
2017年 | 195篇 |
2016年 | 200篇 |
2015年 | 267篇 |
2014年 | 330篇 |
2013年 | 423篇 |
2012年 | 706篇 |
2011年 | 729篇 |
2010年 | 415篇 |
2009年 | 390篇 |
2008年 | 592篇 |
2007年 | 627篇 |
2006年 | 592篇 |
2005年 | 666篇 |
2004年 | 566篇 |
2003年 | 542篇 |
2002年 | 559篇 |
2001年 | 73篇 |
2000年 | 58篇 |
1999年 | 89篇 |
1998年 | 119篇 |
1997年 | 73篇 |
1996年 | 69篇 |
1995年 | 46篇 |
1994年 | 60篇 |
1993年 | 52篇 |
1992年 | 21篇 |
1991年 | 25篇 |
1990年 | 31篇 |
1989年 | 20篇 |
1988年 | 21篇 |
1987年 | 20篇 |
1986年 | 13篇 |
1985年 | 13篇 |
1984年 | 14篇 |
1983年 | 13篇 |
1982年 | 12篇 |
1981年 | 16篇 |
1980年 | 11篇 |
1979年 | 14篇 |
1976年 | 10篇 |
1975年 | 6篇 |
1973年 | 7篇 |
1972年 | 7篇 |
1971年 | 5篇 |
排序方式: 共有9735条查询结果,搜索用时 15 毫秒
61.
Orianne Constant Patricia Gil Jonathan Barthelemy Karine Bollor Vincent Foulongne Caroline Desmetz Agns Leblond Isabelle Desjardins Sophie Pradier Aurlien Jouli Alain Sandoz Rayane Amaral Michel Boisseau Ignace Rakotoarivony Thierry Baldet Albane Marie Benoît Frances Florence Reboul Salze Bachirou Tinto Philippe Van de Perre Sara Salinas Ccile Beck Sylvie Lecolinet Serafin Gutierrez Yannick Simonin 《Euro surveillance : bulletin européen sur les maladies transmissibles = European communicable disease bulletin》2022,27(25)
BackgroundWest Nile virus (WNV) and Usutu virus (USUV), two closely related flaviviruses, mainly follow an enzootic cycle involving mosquitoes and birds, but also infect humans and other mammals. Since 2010, their epidemiological situation may have shifted from irregular epidemics to endemicity in several European regions; this requires confirmation, as it could have implications for risk assessment and surveillance strategies.AimTo explore the seroprevalence in animals and humans and potential endemicity of WNV and USUV in Southern France, given a long history of WNV outbreaks and the only severe human USUV case in France in this region.MethodsWe evaluated the prevalence of WNV and USUV in a repeated cross-sectional study by serological and molecular analyses of human, dog, horse, bird and mosquito samples in the Camargue area, including the city of Montpellier, between 2016 and 2020.ResultsWe observed the active transmission of both viruses and higher USUV prevalence in humans, dogs, birds and mosquitoes, while WNV prevalence was higher in horses. In 500 human samples, 15 were positive for USUV and 6 for WNV. Genetic data showed that the same lineages, WNV lineage 1a and USUV lineage Africa 3, were found in mosquitoes in 2015, 2018 and 2020.ConclusionThese findings support existing literature suggesting endemisation in the study region and contribute to a better understanding of USUV and WNV circulation in Southern France. Our study underlines the importance of a One Health approach for the surveillance of these viruses. 相似文献
62.
Juri Sromicki Mathias Van Hemelrijck Martin O Schmiady Bernard Krüger Mohammed Morjan Dominique Bettex Paul R Vogt Thierry P Carrel Carlos-A Mestres 《Interactive Cardiovascular and Thoracic Surgery》2022,35(1)
Open in a separate window OBJECTIVESOral anticoagulation prior to emergency surgery is associated with an increased risk of perioperative bleeding, especially when this therapy cannot be discontinued or reversed in time. The goal of this study was to analyse the impact of different oral anticoagulants on the outcome of patients who underwent emergency surgery for acute type A aortic dissection (ATAAD).METHODSThis was a single-centre retrospective study of patients treated with oral anticoagulation at the time of surgery for ATAAD. Outcomes of patients on new oral anticoagulant (NOAC) therapy were compared to respective outcomes of patients on Coumadin. Additionally, a survival analysis was performed comparing these 2 groups with patients who were operated on with no prior anticoagulation.RESULTSBetween January 2013 and April 2020, a total of 437 patients (63.8 ± 11.8 years, 68.4% male) received emergency surgery for ATAAD; 35 (8%) were taking oral anticoagulation at the time of hospital admission: 20 received phenprocoumon; 14, rivaroxaban; and 1, dabigatran. Compared to Coumadin, NOAC was associated with a greater need for blood-product transfusions and haemodynamic compromise. Operative mortality was 53% in the NOAC group and 30% in the Coumadin group. A 5-year survival analysis showed no significant difference between the NOAC and the Coumadin group (P = 0.059). Compared to 402 patients treated during the study period without anticoagulation, patients taking NOAC had significantly worse survival (P = 0.001), whereas that effect was not observed in patients undergoing surgery who were taking Coumadin (P = 0.99).CONCLUSIONSEmergency surgery for ATAAD in patients taking NOAC is associated with high morbidity and mortality. NOAC are a major risk factor for uncontrollable bleeding and haemodynamic compromise. New treatment strategies must be defined to improve surgical outcomes in these high-risk patients. 相似文献
63.
Laura Garcia Tom Woudenberg Jason Rosado Adam H. Dyer Franoise Donnadieu Delphine Planas Timothe Bruel Olivier Schwartz Thierry Prazuck Aurlie Velay Samira Fafi-Kremer Isabella Batten Conor Reddy Emma Connolly Matt McElheron Sean P. Kennelly Nollaig M. Bourke Michael T. White Stphane Pelleau 《Viruses》2022,14(7)
Serological assays capable of measuring antibody responses induced by previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been critical tools in the response to the COVID-19 pandemic. In this study, we use bead-based multiplex assays to measure IgG and IgA antibodies and IgG avidity to five SARS-CoV-2 antigens (Spike (S), receptor-binding domain (RBD), Nucleocapsid (N), S subunit 2, and Membrane-Envelope fusion (ME)). These assays were performed in several cohorts of healthcare workers and nursing home residents, who were followed for up to eleven months after SARS-CoV-2 infection or up to six months after vaccination. Our results show distinct kinetic patterns of antibody quantity (IgG and IgA) and avidity. While IgG and IgA antibody levels waned over time, with IgA antibody levels waning more rapidly, avidity increased with time after infection or vaccination. These contrasting kinetic patterns allow for the estimation of time since previous SARS-CoV-2 infection. Including avidity measurements in addition to antibody levels in a classification algorithm for estimating time since infection led to a substantial improvement in accuracy, from 62% to 78%. The inclusion of antibody avidity in panels of serological assays can yield valuable information for improving serosurveillance during SARS-CoV-2 epidemics. 相似文献
64.
Guilmot Antoine Maldonado Slootjes Sofia Sellimi Amina Bronchain Maroussia Hanseeuw Bernard Belkhir Leila Yombi Jean Cyr De Greef Julien Pothen Lucie Yildiz Halil Duprez Thierry Fillée Catherine Anantharajah Ahalieyah Capes Antoine Hantson Philippe Jacquerye Philippe Raymackers Jean-Marc London Frederic El Sankari Souraya Ivanoiu Adrian Maggi Pietro van Pesch Vincent 《Journal of neurology》2021,268(3):751-757
Journal of Neurology - Evidence of immune-mediated neurological syndromes associated with the severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection is limited. We therefore... 相似文献
65.
66.
Enrico Franceschi Roger Stupp Martin J. van den Bent Carla van Herpen Florence Laigle Donadey Thierry Gorlia Monika Hegi Benoit Lhermitte Lewis C. Strauss Anouk Allgeier Denis Lacombe Alba A. Brandes 《Neuro-oncology》2012,14(12):1503-1510
The treatment of patients with recurrent glioblastoma remains a major oncologic problem, with median survival after progression of 7–9 months. To determine the maximum tolerated dose and dose-limiting toxicity (DLT), the combination of dasatinib and cyclonexyl-chloroethyl-nitrosourea (CCNU) was investigated in this setting. The study was designed as multicenter, randomized phase II trial, preceded by a lead-in safety phase. The safety component reported here, which also investigated pharmacokinetics and preliminary clinical activity, required expansion and is therefore considered a phase I part to establish a recommended dosing regimen of the combination of CCNU (90–110 mg/m2) and dasatinib (100–200 mg daily). Overall, 28 patients were screened, and 26 patients were enrolled. Five dose levels were explored. DLTs, mainly myelosuppression, occurred in 10 patients. Grade 3 or 4 neutropenia was recorded in 7 patients (26.9%) and thrombocytopenia in 11 patients (42.3%). No significant effect of CCNU coadministration on dasatinib pharmacokinetics was found. Median progression-free survival (PFS) was 1.35 months (95% confidence interval: 1.2–1.4) and 6-month PFS was 7.7%. In this phase I study of recurrent glioblastoma patients, the combination of CCNU and dasatinib showed significant hematological toxicities and led to suboptimal exposure to both agents. 相似文献
67.
68.
69.
Hanspeter Huber Guillaume André Francine Rumeau Pierre Journeau Thierry Haumont Pierre Lascombes 《Journal of children's orthopaedics》2012,6(2):119-123
Purpose
Distal femoral fractures are quite common in nonambulating patients with myopathies, as they present marked osteoporosis. The deterioration of preexisting knee flexion contracture is a known problem, as these fractures are usually angulated posteriorly. The goals of treatment are to reduce immobilization and bed rest to a minimum, prevent function loss, and prevent refracture. The aim of our work was to investigate if these goals can be achieved by an operative treatment with closed reduction and flexible intramedullary nailing (FIN). 相似文献70.
Thierry Bautrant Michel Grino Corinne Peloso Frédéric Schiettecatte Magali Planelles Charles Oliver Caroline Franqui 《Journal of the American Medical Directors Association》2019,20(3):377-381